Pancreatic cancer is the deadliest and most difficult tumor to diagnose.

Pancreatic cancer is the deadliest tumor in our country and is more difficult to diagnose. The Cancer CRIS Foundation contributed to the first major study of its origins, that is, finding out where it came from. And this type of cancer is the most aggressive because its symptoms go unnoticed. as reported by Maria Perez.

On World Pancreatic Cancer Day, wear concentrate V prevention because only 8% of diagnosed patients survive more than four years. “That’s because there is no early diagnosis because we don’t have a biomarker that allows us to do that. Moreover, it responds very poorly to current chemotherapy,” explains Dr. Meritxell Rovira, a researcher at the foundation.

Symptoms pancreatic cancer They are vague, including simple abdominal pain or weight loss. “This is a tumor that has symptoms very general: back pain, weight loss, changes in toilet habits that are not directly related to the tumor,” says Rovira.

This is one of the aspects causing late diagnosis. The CRIS Cancer Foundation launched the first major study into its origins with one goal: “To enable early detection of a biomarker in the blood. We explore the formation tumors

from first cell which generates them and then provides personalized treatment.”

The development of multiple treatments is important because not all patients respond to them in the same way, and this is an aspect that sets them apart from other tumors. It is connected with the cell that originates it in every person. “Pancreatic cancer, diagnosed sooner or later, is a two-centimeter tumor. high mortality rate and for breast cancer, the survival rate is 95%,” emphasizes Rovira.

The most worrying thing right now is the rising incidence among people. everyone is youngerbelow 40. “Tobacco increases the risk of diabetes, diet, obesity, sedentary lifestyle and stress,” the researcher warns of this study, which shows some light at the end of the tunnel and brings hope to an unknown world. Pancreatic cancer leaves 8000 deaths

annually in Spain, and an additional 10,000 people are expected to be diagnosed in 2024.